A U01 grant from the National Institute on Drug Abuse (NIDA) was awarded to Dr. Robert Hitzemann, Dr. Suzanne Mitchell, and Dr. Abraham Palmer. The grant, titled “Identification of genetic features of delay discounting using a heterogeneous stock rat model,” will start on July 1, 2018 and will end April 30, 2023.
Drs. Robert Hitzemann, Suzanne Mitchell, and Abraham Palmer awarded NIDA U01 grant
Posted under: Funding & Grants